Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: The role of US, MRI and FDG-PET/TC scans to assess residual neck disease

2014 ◽  
Vol 42 (8) ◽  
pp. 1834-1839 ◽  
Author(s):  
Raul Pellini ◽  
Valentina Manciocco ◽  
Mario Turri-Zanoni ◽  
Antonello Vidiri ◽  
Giuseppe Sanguineti ◽  
...  
Keyword(s):  
Neck Dissection ◽  
Squamous Cell ◽  
Fdg Pet ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Neck Disease

scholarly journals Elective Neck Dissection can Improve the Overall Survival and Cancer-Specific Survival of T3cN0M0 Glottic Squamous Cell Cancer

2021 ◽  
Author(s):  
Zhimou Cai ◽  
Lin Chen ◽  
Jiangwei Zhang ◽  
Yihui Wen ◽  
Wen-bin Lei
Keyword(s):  
Overall Survival ◽  
Neck Dissection ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Elective Neck Dissection ◽  
Cancer Specific Survival ◽  
Node Negative ◽  
Considerable Discussion

Abstract How to treat clinically node-negative (cN0) neck in larynx squamous cell cancer (LSCC) has been subject to considerable discussion. The role of elective neck dissection (END) in patients with T3 glottic squamous cell cancer (GSCC) with cN0 is remain unclear. The objective of this study is to elucidate the role of END in improve the outcome of T3cN0M0 GSCC. Patients with T3cN0M0 GSCC in the Surveillance, Epidemiology, and End Results database (SEER) from 2004 to 2015 were extracted and stratified into END and Non-END cohorts, we found that only 22–58% T3cN0M0 GSCC were performed with END. After Propensity score matching (PSM), END cohort had better overall survival (OS) (median survival time: 93 vs 40 months, respectively; p < 0.0001) and cancer-specific survival (CSS) (HR 0.40, 95%CI 0.26 to 0.64, p = 0.0012) than non-END cohort. In addition, Subgroup analysis also indicated END cohort had better OS or CSS than non-END cohort.This study demonstrated that in patients with T3cN0M0 GSCC, END significantly associated with better survival outcomes compared with non-END.

scholarly journals Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PET

2003 ◽  
Vol 129 (11) ◽  
pp. 1173 ◽  
Author(s):  
David L. Schwartz ◽  
Joseph Rajendran ◽  
Bevan Yueh ◽  
Marc Coltrera ◽  
Yoshimi Anzai ◽  
...  
Keyword(s):  
Head And Neck ◽  
Squamous Cell ◽  
Fdg Pet ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Extended Field ◽  
Neck Squamous Cell Cancer

The role of salvage surgery for recurrence of esophageal squamous cell cancer

2006 ◽  
Vol 32 (5) ◽  
pp. 544-547 ◽  
Author(s):  
S. Natsugoe ◽  
H. Okumura ◽  
M. Matsumoto ◽  
Y. Uchikado ◽  
T. Setoyama ◽  
...  
Keyword(s):  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Salvage Surgery ◽  
Cell Cancer ◽  
Esophageal Squamous Cell Cancer

The role of the immunohistochemical marker p40 in the differential diagnosis of adenocarcinoma and nonkeratinizing squamous cell cancer of the lung

2020 ◽  
Vol 82 (5) ◽  
pp. 50
Author(s):  
E.M. Olyushina ◽  
M.M. Byakhova ◽  
L.E. Zavalishina ◽  
Yu.Yu. Andreeva ◽  
A.B. Semenova ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Immunohistochemical Marker ◽  
Cancer Of The Lung
Sign in / Sign up

Export Citation Format

Share Document